Jessica Tassan
Stock Analyst at Piper Sandler
(1.12)
# 3,778
Out of 5,113 analysts
79
Total ratings
31.82%
Success rate
-11.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Reiterates: Overweight | $99 → $101 | $77.72 | +29.95% | 6 | Dec 10, 2025 | |
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $14.90 | +67.79% | 7 | Nov 26, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $47.25 | +50.26% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $327.42 | +27.36% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $16.55 | +105.44% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $3.99 | +351.13% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.35 | +70.21% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $41.02 | +109.65% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $43.65 | +58.08% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $259.40 | +4.86% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $4.66 | +71.67% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $271.89 | +37.56% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $20.42 | +2.84% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.23 | +65.98% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $46.84 | +49.44% | 4 | Aug 2, 2023 |
CVS Health
Dec 10, 2025
Reiterates: Overweight
Price Target: $99 → $101
Current: $77.72
Upside: +29.95%
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $14.90
Upside: +67.79%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $47.25
Upside: +50.26%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $327.42
Upside: +27.36%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $16.55
Upside: +105.44%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $3.99
Upside: +351.13%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.35
Upside: +70.21%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $41.02
Upside: +109.65%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $43.65
Upside: +58.08%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $259.40
Upside: +4.86%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.66
Upside: +71.67%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $271.89
Upside: +37.56%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $20.42
Upside: +2.84%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.23
Upside: +65.98%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $46.84
Upside: +49.44%